Constantinoiu S, Gheorghe M, Popa L, Ciocea C, Iosif C, Tiutiuca R, Iordache A, Cordoş I
Chirurgia (Bucur). 2015 May-Jun;110(3):300-7.
GIST are rare mesenchymal tumors of the digestive tract (less than 1% of the digestive tract neoplasia). Of these, less than 1% are found in the esophagus. Surgery is the main treatment of GIST and is supported by targeted therapy with tyrosine kinase inhibitors like imatinibmesylate. We present the case of a female patient of 51 years, admitted in our clinic for a bulky tumor in the posterior mediastinum, diagnosed after investigations performed for fatigue for the great efforts. Clinical examination was unspecific. Chest X-ray and thoraco-abdominal CT identified a widening of the mediastinum through a posterior mediastinal tumor mass, determining a deviation to the left of the thoracic esophagus without causing not abledysphagia or respiratory symptoms. It was decided surgery by thoracotomy in V right intercostal space and total excision of the tumor was performed. Histopathology examination confirmed the preoperative suspicion of esophageal GIST. Prognosis is reserved, the risk of relapse is very high given the fact that the tumor was extracted fragmented. Currently the patient is under treatment with imatinib mesylate and entered into clinical and imaging follow-up program, according to clinical guidelines.
胃肠道间质瘤(GIST)是消化道罕见的间叶组织肿瘤(占消化道肿瘤的比例不到1%)。其中,食管GIST的比例不到1%。手术是GIST的主要治疗方法,并辅以酪氨酸激酶抑制剂(如甲磺酸伊马替尼)进行靶向治疗。我们报告一例51岁女性患者,因后纵隔巨大肿瘤入住我院。该患者因疲劳进行检查时发现该肿瘤,经详细检查后确诊。临床检查未发现特异性表现。胸部X线和胸腹部CT显示后纵隔肿瘤肿块导致纵隔增宽,致使胸段食管向左偏移,但未引起吞咽困难或呼吸症状。决定在右侧第5肋间行开胸手术,并完整切除肿瘤。组织病理学检查证实术前怀疑的食管GIST诊断。鉴于肿瘤为分块切除,预后不佳,复发风险很高。目前,患者正在按照临床指南接受甲磺酸伊马替尼治疗,并进入临床和影像学随访程序。